CAS 467458-02-2: 1H-Indole-3-ethanamine, 6-fluoro-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]-, hydrochloride (1:1)

2-(6-Fluoro-1H-Indol-3-Yl)-N-(3-(2,2,3,3-Tetrafluoropropoxy)Benzyl)Ethanamine Hydrochloride

Idalopirdine Hydrochloride

N-[2-(6-Fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzenesulfonamide (6FIAU) is a long-acting drug that has been shown to improve memory in patients with Alzheimer's disease. 6FIAU has also been shown to be effective against symptoms of depression. This drug binds reversibly to the 5HT6 receptor and inhibits the activity of this receptor by competitive inhibition. The preparation process includes crystallization from an organic solvent such as ethyl acetate or ethanol. Crystals can be grown from a solution by seeding with a small amount of material containing crystals. The 2D powder diffraction pattern was obtained using Cu Kα radiation and a Bruker D8 Advance X-Ray Diffractometer at room temperature. 6FIAU can exist in two polymorphic forms: one form is crystalline and the

Idalopirdine Hydrochloride (Lu AE58054 Hydrochloride) is an in-vivo binding affinity and effect, in-vitro selectivity and potency of 5-HT(6)R antagonist (Ki: 0.